Senate Finance Committee Chairman Chuck Grassley (R-Ia.) wrote on Twitter on Monday that he hoped the executives “don’t try to blame everyone but themselves/take no responsibility for their role in fixing the problem.”
Caforio and other executives called for reform of rebates that PBMs receive from drugmakers. And he spoke out against a Trump administration plan that would seek to lower prescription drug prices for the government’s Medicare program by basing prices for some medications on the lower prices paid in other countries, where governments directly or indirectly set prices.